MAHA ELEVATE: Transforming Medicare with Lifestyle Interventions
Explore MAHA ELEVATE, a groundbreaking CMS initiative promoting lifestyle interventions for better Medicare outcomes. Funding opportunities available for innovative organizations.
Explore MAHA ELEVATE, a groundbreaking CMS initiative promoting lifestyle interventions for better Medicare outcomes. Funding opportunities available for innovative organizations.
Discover how Medicare is enhancing access to GLP-1 drugs for weight management, offering significant cost relief and impacting health outcomes positively.
CMS proposes new payment structures for outpatient services under Medicare, impacting provider compliance and drug pricing, inviting stakeholder feedback by Aug 31, 2026.
CMS introduces resources and waivers to ensure healthcare access in Guam and CNMI post-Super Typhoon Bavi, enhancing support for affected communities.
CMS proposes to cut 340B drug reimbursement rates for 2027, seeking to align payments with actual acquisition costs and reduce expenditures by $5.7 billion.
Explore UnitedHealth Group's revised earnings outlook and stock potential ahead of its earnings release, with insights on Medicare Advantage impacts and value assessments.
Discover how Medicare's new initiative allows access to GLP-1 weight loss medications at $50, promoting healthy living for eligible individuals.
Blue Cross Blue Shield of North Carolina resumes managing the State Health Plan from Aetna in 2028, promising improved service and cost savings for members.
Discover critical 2026 regulatory changes by CMS and FDA that will impact reimbursement, prescribing practices, and patient care throughout healthcare specialties.
Learn how IRMAA impacts Medicare Part B premiums. Essential for retirees to understand potential increases due to income changes and plan effectively.